ArticleBMC biotechnology2024
The effect of plasma activated water on antimicrobial activity of silver nanoparticles biosynthesized by cyanobacterium Alborzia kermanshahica.
Article in BMC biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSilver nanoparticles are extensively researched for their antimicrobial properties. Cold atmospheric plasma, containing reactive oxygen and nitrogen species, is increasingly used for disinfecting microbes, wound healing, and cancer treatment. Therefore, this study examined the effect of water activated by dielectric barrier discharge (DBD) plasma and gliding arc discharge plasma on the antimicrobial activity of silver nanoparticles from Alborzia kermanshahica.
methodsSilver nanoparticles were synthesized using the boiling method, as well as biomass from Alborzia kermanshahica extract grown in water activated by DBD and GA plasma. The physicochemical properties of the synthesized nanoparticles were evaluated using UV-vis spectroscopy, Fourier-transform infrared (FTIR) spectroscopy, dynamic light scattering (DLS), zeta potential analysis, transmission electron microscopy (TEM), and gas chromatography-mass spectrometry (GC-MS) analysis. Additionally, the disk diffusion method was used to assess the antimicrobial efficacy of the manufactured nanoparticles against both Gram-positive and Gram-negative bacteria.
resultsThe spectroscopy results verified the presence of silver nanoparticles, indicating their biosynthesis. The highest amount of absorption (1.049) belonged to the nanoparticles synthesized by boiling under GA plasma conditions. Comparing the FTIR spectra of the plasma-treated samples with DBD and GA revealed that the DBD-treated samples had more intense peaks, indicating that the DBD method proved to be more effective in enhancing the functional groups on the silver nanoparticles. The DLS results revealed that the boiling method synthesized silver nanoparticles under DBD plasma treatment had a smaller particle size (149.89 nm) with a PDI of 0.251 compared to the GA method, and the DBD method produced nanoparticles with a higher zeta potential (27.7 mV) than the GA method, indicating greater stability of the biosynthesized nanoparticles. Moreover, the highest antimicrobial properties against E. coli (14.333 ± 0.47 mm) were found in the DBD-treated nanoparticles. TEM tests confirmed that spherical nanoparticles attacked the E. coli bacterial membrane, causing cell membrane destruction and cell death. The GC-MS results showed that compounds like 2-methylfuran, 3-methylbutanal, 2-methylbutanal, 3-hydroxy-2-butanone, benzaldehyde, 2-phenylethanol, and 3-octen-2-ol were much higher in the samples that were treated with DBD compared to the samples that were treated with GA plasma.
conclusionThe research indicated that DBD plasma was more efficient than GA plasma in boosting the antimicrobial characteristics of nanoparticles. These results might be a cornerstone for future advancements in utilizing cold plasma to create nanoparticles with enhanced antimicrobial properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.